To include your compound in the COVID-19 Resource Center, submit it here.

Takeda, Lundbeck get second CRL for Trintellix in MDD

In June, H. Lundbeck A/S (CSE:LUN) and Takeda Pharmaceutical Co.

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE